Whitehawk Therapeutics, Inc. - Common stock (WHWK)

Historical Holders from Q3 2021 to Q3 2025

Symbol
WHWK on Nasdaq
Type / Class
Equity / Common stock
Shares outstanding
47,144,064
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
28,831,370
Holdings value
$54,340,996
% of all portfolios
0%
Number of holders
39
Number of buys
9
Number of sells
13
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Whitehawk Therapeutics, Inc. - Common stock (WHWK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avoro Capital Advisors LLC 20% +37% $18,349,040 +$12,832,820 11,914,961 +233% BEHZAD AGHAZADEH 28 Feb 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 10% $7,280,365 4,727,510 SUVRETTA CAPITAL MANAGEMENT, LLC 04 Mar 2025
ORBIMED ADVISORS LLC 8.9% $6,415,640 4,166,000 OrbiMed Advisors LLC 31 Mar 2025
ABG Management Ltd. 6.3% $4,488,492 2,914,605 Fan Yu 04 Mar 2025
Coastlands Capital LP 6% $5,074,587 2,819,215 Coastlands Capital LP 19 Aug 2025
BML Investment Partners, L.P. 5% -49% $3,749,900 -$331,178 2,435,000 0% Leonard Braden Michael 05 Mar 2025
QVT Financial LP 9.4% $3,563,101 2,313,702 QVT Financial LP 31 Dec 2024
Desai Neil 4.9% -48% $3,500,329 +$14,438 2,272,941 +0.41% Neil Desai 04 Mar 2025
ACUTA CAPITAL PARTNERS, LLC 7.8% $2,958,797 1,921,297 Anupam Dalal 19 Dec 2024
EcoR1 Capital, LLC 1.4% $531,690 345,253 EcoR1 Capital, LLC 31 Dec 2024
Point72 Asset Management, L.P. 0% -100% $7,834 -$2,256,445 5,087 -100% Point72 Asset Management, L.P. 31 Mar 2025
Satter Muneer A 0% $1,015 659 Satter Muneer A 31 Dec 2024
As of 30 Sep 2025 Whitehawk Therapeutics, Inc. - Common stock (WHWK) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28,831,370 shares of 47,144,064 outstanding shares and own 61% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Whitehawk Therapeutics, Inc. - Common stock (WHWK) own 61% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
QVT Financial LP 9.8% 4,615,709 0% 0.92% $8,331,355
ORBIMED ADVISORS LLC 8.8% 4,166,000 0% 0.19% $7,915,400
SUVRETTA CAPITAL MANAGEMENT, LLC 7.8% 3,700,000 0% 0.21% $7,030,000
ACUTA CAPITAL PARTNERS, LLC 7.2% 3,410,402 0% 6.7% $6,479,764
Avoro Capital Advisors LLC 6% 2,849,402 0% 0.07% $5,413,864
Siren, L.L.C. 4.4% 2,082,000 0% 0.15% $3,955,800
Yu Fan 4.4% 2,070,000 0% 5.1% $3,933,000
VANGUARD GROUP INC 2.8% 1,342,907 +2.1% 0% $2,551,523
ACORN CAPITAL ADVISORS, LLC 2.4% 1,139,363 0% 1.1% $2,164,790
Ally Bridge Group (NY) LLC 1.7% 817,939 0% 1.3% $1,554,084
RENAISSANCE TECHNOLOGIES LLC 0.97% 457,422 -0.17% 0% $869,102
STEMPOINT CAPITAL LP 0.9% 424,082 0.16% $805,756
GEODE CAPITAL MANAGEMENT, LLC 0.81% 381,754 +2.5% 0% $725,695
Peapod Lane Capital LLC 0.64% 303,585 +25% 0.52% $577,064
BlackRock, Inc. 0.63% 296,158 -0.72% 0% $562,701
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.46% 215,284 -32% 0.01% $409,040
CITADEL ADVISORS LLC 0.3% 140,220 +391% 0% $266,418
Squarepoint Ops LLC 0.18% 83,660 +36% 0% $158,954
NORTHERN TRUST CORP 0.15% 72,164 -22% 0% $137,111
STATE STREET CORP 0.15% 68,737 0% 0% $130,600
DIMENSIONAL FUND ADVISORS LP 0.09% 44,115 -38% 0% $83,818
Stonepine Capital Management, LLC 0.07% 35,253 0.05% $66,981
ABG Innovation Capital Partners III GP Ltd 0.06% 26,666 0% 100% $50,665
ACADIAN ASSET MANAGEMENT LLC 0.06% 26,206 0% $49,000
JANE STREET GROUP, LLC 0.05% 25,215 -76% 0% $47,908

Institutional Holders of Whitehawk Therapeutics, Inc. - Common stock (WHWK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 28,831,370 $54,340,996 -$1,110,993 $1.90 39
2025 Q2 29,433,136 $54,608,497 -$4,256,988 $1.87 38
2025 Q1 31,810,129 $56,220,211 +$29,068,777 $1.78 48
2024 Q4 14,964,504 $47,212,864 +$5,023,549 $3.16 51
2024 Q3 11,974,976 $24,667,146 +$1,827,419 $2.06 51
2024 Q2 11,470,837 $16,746,144 -$3,322,352 $1.46 63
2024 Q1 13,209,848 $30,910,957 +$1,200,705 $2.34 59
2023 Q4 12,774,914 $25,805,815 -$10,140,228 $2.02 62
2023 Q3 14,216,215 $68,812,109 +$1,540,803 $4.84 69
2023 Q2 13,790,216 $94,355,740 -$714,623 $6.84 65
2023 Q1 13,831,279 $100,129,503 -$16,765,639 $7.24 68
2022 Q4 15,301,334 $192,201,785 +$3,741,246 $12.83 73
2022 Q3 14,991,886 $211,814,933 +$32,802,356 $14.13 65
2022 Q2 12,823,915 $158,008,315 +$4,841,924 $12.32 65
2022 Q1 12,574,186 $213,400,829 -$7,136,755 $16.97 51
2021 Q4 12,184,052 $294,238,682 +$23,944,526 $24.15 44
2021 Q3 11,096,563 $324,110,000 +$324,110,000 $29.37 30